Bispecific single chain Fv antibody molecules and methods of use therof
US8980258B2 · kind B2 · utility
0Cited by
27References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 10, 2012 |
| Grant date | Mar 17, 2015 |
| Priority date | — |
| Expiry date | Mar 29, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/71
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.